197 related articles for article (PubMed ID: 27758701)
21. A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota.
Zhao L; Zhang Q; Ma W; Tian F; Shen H; Zhou M
Food Funct; 2017 Dec; 8(12):4644-4656. PubMed ID: 29152632
[TBL] [Abstract][Full Text] [Related]
22. Polyphenolic Compounds and Gut Microbiome in Cardiovascular Diseases.
McGrail L; Garelnabi M
Curr Pharm Biotechnol; 2020; 21(7):578-586. PubMed ID: 31713494
[TBL] [Abstract][Full Text] [Related]
23. Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota.
Ding QY; Tian JX; Li M; Lian FM; Zhao LH; Wei XX; Han L; Zheng YJ; Gao ZZ; Yang HY; Fang XY; Tong XL
Front Cell Infect Microbiol; 2020; 10():530160. PubMed ID: 33194785
[TBL] [Abstract][Full Text] [Related]
24. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
Tuohy KM; Fava F; Viola R
Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
[TBL] [Abstract][Full Text] [Related]
25. Gut Microbiota: A New Marker of Cardiovascular Disease.
Garcia-Rios A; Torres-Peña JD; Perez-Jimenez F; Perez-Martinez P
Curr Pharm Des; 2017; 23(22):3233-3238. PubMed ID: 28317481
[TBL] [Abstract][Full Text] [Related]
26. Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases.
Panyod S; Wu WK; Chen CC; Wu MS; Ho CT; Sheen LY
J Tradit Complement Med; 2023 Mar; 13(2):107-118. PubMed ID: 36970453
[TBL] [Abstract][Full Text] [Related]
27. Insoluble Dietary Fiber from Pear Pomace Can Prevent High-Fat Diet-Induced Obesity in Rats Mainly by Improving the Structure of the Gut Microbiota.
Chang S; Cui X; Guo M; Tian Y; Xu W; Huang K; Zhang Y
J Microbiol Biotechnol; 2017 Apr; 27(4):856-867. PubMed ID: 28173692
[TBL] [Abstract][Full Text] [Related]
28. Xenobiotics: Interaction with the Intestinal Microflora.
Lu K; Mahbub R; Fox JG
ILAR J; 2015; 56(2):218-27. PubMed ID: 26323631
[TBL] [Abstract][Full Text] [Related]
29. Diet, gut microbiota and cognition.
Proctor C; Thiennimitr P; Chattipakorn N; Chattipakorn SC
Metab Brain Dis; 2017 Feb; 32(1):1-17. PubMed ID: 27709426
[TBL] [Abstract][Full Text] [Related]
30. Effects of Ligustrum robustum on gut microbes and obesity in rats.
Xie ZM; Zhou T; Liao HY; Ye Q; Liu S; Qi L; Huang J; Zuo HJ; Pei XF
World J Gastroenterol; 2015 Dec; 21(46):13042-54. PubMed ID: 26676281
[TBL] [Abstract][Full Text] [Related]
31. Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.
Mas-Capdevila A; Teichenne J; Domenech-Coca C; Caimari A; Del Bas JM; Escoté X; Crescenti A
Nutrients; 2020 May; 12(5):. PubMed ID: 32443766
[TBL] [Abstract][Full Text] [Related]
32. Herbal drugs against cardiovascular disease: traditional medicine and modern development.
Li L; Zhou X; Li N; Sun M; Lv J; Xu Z
Drug Discov Today; 2015 Sep; 20(9):1074-86. PubMed ID: 25956424
[TBL] [Abstract][Full Text] [Related]
33. Daesiho-Tang Is an Effective Herbal Formulation in Attenuation of Obesity in Mice through Alteration of Gene Expression and Modulation of Intestinal Microbiota.
Hussain A; Yadav MK; Bose S; Wang JH; Lim D; Song YK; Ko SG; Kim H
PLoS One; 2016; 11(11):e0165483. PubMed ID: 27812119
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiota and obesity: lessons from the microbiome.
Cani PD
Brief Funct Genomics; 2013 Jul; 12(4):381-7. PubMed ID: 23616309
[TBL] [Abstract][Full Text] [Related]
35. Melatonin prevents obesity through modulation of gut microbiota in mice.
Xu P; Wang J; Hong F; Wang S; Jin X; Xue T; Jia L; Zhai Y
J Pineal Res; 2017 May; 62(4):. PubMed ID: 28199741
[TBL] [Abstract][Full Text] [Related]
36. Early-Life Antibiotic Exposure, Gut Microbiota Development, and Predisposition to Obesity.
Azad MB; Moossavi S; Owora A; Sepehri S
Nestle Nutr Inst Workshop Ser; 2017; 88():67-79. PubMed ID: 28346924
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
38. A role for whey-derived lactoferrin and immunoglobulins in the attenuation of obesity-related inflammation and disease.
Brimelow RE; West NP; Williams LT; Cripps AW; Cox AJ
Crit Rev Food Sci Nutr; 2017 May; 57(8):1593-1602. PubMed ID: 26068582
[TBL] [Abstract][Full Text] [Related]
39. Anti-obesity effects of gut microbiota are associated with lactic acid bacteria.
Tsai YT; Cheng PC; Pan TM
Appl Microbiol Biotechnol; 2014 Jan; 98(1):1-10. PubMed ID: 24232731
[TBL] [Abstract][Full Text] [Related]
40. The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease.
Sanduzzi Zamparelli M; Compare D; Coccoli P; Rocco A; Nardone OM; Marrone G; Gasbarrini A; Grieco A; Nardone G; Miele L
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
